BCA
RETA

Berman Capital Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Berman Capital Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$5K Buy
2021
Q2 		$3K Buy
2021
Q1 		$0 Buy
2020
Q4 		– Sell
2020
Q3 		$0 Hold
2020
Q2 		$1K Buy